Back to Results
First PageMeta Content
Recombinant proteins / Peptide hormones / Generally Accepted Accounting Principles / Biotechnology / Eli Lilly and Company / Insulin analog / Biosimilar / Biocon / Trastuzumab / Pharmaceutical industry in India / Kiran Mazumdar-Shaw / Biopharmaceutical


FINAL Press Release Biocon Reports a Strong Q1FY17 Revenues at Rs 952 Crore, up by 11 %; EBITDA Up 15% to Rs 271 Crore
Add to Reading List

Document Date: 2016-07-21 12:08:20


Open Document

File Size: 521,99 KB

Share Result on Facebook